Home Amgen: Allowing Dividend Growth Investors To Capitalize On The Biotech Sell-Off
 

Keywords :   


Amgen: Allowing Dividend Growth Investors To Capitalize On The Biotech Sell-Off

2014-04-01 12:54:12| Biotech - Topix.net

In my opinion, Amgen is the only viable option for a conservative income investor looking for large-cap exposure to biotech.

Tags: growth allowing investors biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.1146 4th year birthdayLive DVD
26.11 LCD
26.11gtk
26.111/28 B-24D LIBERATOR
26.11seventeen SPILL THE FEELS standard
26.11
26.11 21 12
26.11lululemon
More »